Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
language:"Undetermined"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=language%3A%22Undetermined%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&page=2
/vufind/Search/Results?filter%5B%5D=language%3A%22Undetermined%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&page=2
Search /vufind/Search2/Results?filter%5B%5D=language%3A%22Undetermined%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&page=2
PubPharm (1.244)
11
Adoptive cell therapy LTFU study : Long-Term Follow-Up (LTFU) of Participants Treated with GSK Adoptive Cell Therapies - Adoptive cell therapy LTFU study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
12
Nonrelapsing secondary progressive multiple sclerosis (NRSPMS) study of Bruton tyrosine kinase (BTK) inhibitor tolebrutinib SAR442168 (HERCULES) : A Phase 3, randomized, double-blind, efficacy and safety study comparing SAR442168 to placebo in participants with nonrelapsing secondary progressive multiple sclerosis - HERCULES
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
13
Dupilumab in CRSsNP : A randomized, double-blind, placebo-controlled, 2-part study to evaluate the efficacy and safety of dupilumab in patients with uncontrolled, chronic rhinosinusitis without nasal polyposis (CRSsNP) - Liberty CRSsNP ORION
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
14
??a p???pt???, p????e?t????, t??a??p???µ???, ??????? d???µ? ??a t?? asf??e?a ?a? t?? ap?te?esµat???t?ta t?? F?e?a???d?? ??a?t? t?? ?µ??da????? ??a t?? ?a?d??a??ta?? t?? pa????sµ???? ???p???? ?a?µa????? st? ?µ?µa ?pe????t?? ?e??stat???? se as?e?e?? µe stefa??a?a ??s? ????? ?p??e?p?µe?? ?s?a?µ?a ?a? ???sµa e????s?? > 35%(FLECA-ED) : ??a p???pt???, p????e?t????, t??a??p???µ???, ??????? d???µ? ??a t?? asf??e?a ?a? t?? ap?te?esµat???t?ta t?? F?e?a???d?? ??a?t? t?? ?µ??da????? ??a t?? ?a?d??a??ta?? t?? pa????sµ???? ???p???? ?a?µa????? st? ?µ?µa ?pe????t?? ?e??stat???? se as?e?e?? µe stefa??a?a ??s? ????? ?p??e?p?µe?? ?s?a?µ?a ?a? ???sµa e????s?? > 35%(FLECA-ED)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
15
Adoptive cell therapy LTFU study : Long-Term Follow-Up (LTFU) of Participants Treated with GSK Adoptive Cell Therapies - Adoptive cell therapy LTFU study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
16
Nonrelapsing secondary progressive multiple sclerosis (NRSPMS) study of Bruton tyrosine kinase (BTK) inhibitor tolebrutinib SAR442168 (HERCULES) : A Phase 3, randomized, double-blind, efficacy and safety study comparing SAR442168 to placebo in participants with nonrelapsing secondary progressive multiple sclerosis - HERCULES
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
17
Dupilumab in CRSsNP : A randomized, double-blind, placebo-controlled, 2-part study to evaluate the efficacy and safety of dupilumab in patients with uncontrolled, chronic rhinosinusitis without nasal polyposis (CRSsNP) - Liberty CRSsNP ORION
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
18
??a p???pt???, p????e?t????, t??a??p???µ???, ??????? d???µ? ??a t?? asf??e?a ?a? t?? ap?te?esµat???t?ta t?? F?e?a???d?? ??a?t? t?? ?µ??da????? ??a t?? ?a?d??a??ta?? t?? pa????sµ???? ???p???? ?a?µa????? st? ?µ?µa ?pe????t?? ?e??stat???? se as?e?e?? µe stefa??a?a ??s? ????? ?p??e?p?µe?? ?s?a?µ?a ?a? ???sµa e????s?? > 35%(FLECA-ED) : ??a p???pt???, p????e?t????, t??a??p???µ???, ??????? d???µ? ??a t?? asf??e?a ?a? t?? ap?te?esµat???t?ta t?? F?e?a???d?? ??a?t? t?? ?µ??da????? ??a t?? ?a?d??a??ta?? t?? pa????sµ???? ???p???? ?a?µa????? st? ?µ?µa ?pe????t?? ?e??stat???? se as?e?e?? µe stefa??a?a ??s? ????? ?p??e?p?µe?? ?s?a?µ?a ?a? ???sµa e????s?? > 35%(FLECA-ED)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
19
Nonrelapsing secondary progressive multiple sclerosis (NRSPMS) study ofBruton tyrosine kinase (BTK) inhibitor tolebrutinib SAR442168(HERCULES) : A Phase 3, randomized, double-blind, efficacy and safety study comparing SAR442168 to placebo in participants with nonrelapsing secondary progressive multiple sclerosis - HERCULES
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
20
Primary progressive multiple sclerosis (PPMS) Study of Bruton's tyrosine kinase (BTK) inhibitor tolebrutinib SAR442168 (PERSEUS) : A Phase 3, randomized, double-blind, efficacy and safety study comparing SAR442168 to placebo in participants with primary progressive multiple sclerosis (PERSEUS) - PERSEUS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
[1]
« Vorheriger
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[125]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Sprache: Unbestimmt
Medienart
1.244
Aufsätze
1.244
E-Artikel
1.244
E-Ressourcen
Zeitschriftentitel
1.244
WHO International Clinical Trials Registry Plat...
Thema
1.244
610
1.244
Recruitment Status: Authorised-recruitment may ...
1.244
Study Type: Interventional
334
Phase: Phase 3
156
Phase: Phase 2
120
Phase: Phase 4
36
Medical Condition: Relapsing Multiple Sclerosis...
34
Phase: Phase 1
28
Medical Condition: Primary Progressive Multiple...
26
Medical Condition: Non-relapsing Secondary Prog...
24
Medical Condition: Muscle Invasive Bladder Canc...
22
Medical Condition: Myelofibrosis MedDRA version...
16
Medical Condition: MULTIPLE MYELOMA MedDRA vers...
14
Medical Condition: Unresectable locally advance...
10
Medical Condition: HIV Infection;Therapeutic ar...
10
Medical Condition: Rheumatoid Arthritis MedDRA ...
8
Medical Condition: ;Therapeutic area: Diseases ...
8
Medical Condition: Solid Tumors MedDRA version:...
6
Medical Condition: ;Therapeutic area: Analytica...
6
Medical Condition: Asthma;Therapeutic area: Dis...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
434
2020-
810
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
Unbestimmt
Haven't found what you're looking for?
Wird geladen...